Literature DB >> 23528641

263.4 kb deletion within the TCF4 gene consistent with Pitt-Hopkins syndrome, inherited from a mosaic parent with normal phenotype.

Ludmila Kousoulidou1, George Tanteles, Maria Moutafi, Carolina Sismani, Philippos C Patsalis, Violetta Anastasiadou.   

Abstract

Pitt-Hopkins syndrome (PTHS) is a rare neurodevelopmental genetic disorder, remaining under-diagnosed due to similarities with other known genetic syndromes. It is mainly characterized by severe intellectual disability, overbreathing, a typical facial gestalt, tendency to epilepsy and is caused by TCF4 haploinsufficiency. We report on a 14-year old boy, born to healthy non-consanguineous parents, with a PTHS spectrum phenotype, presenting with moderate to severe developmental delay, severe speech delay and facial dysmorphism. Genetic investigation using array-based comparative genomic hybridization (array-CGH) with a 400K custom array, revealed a 263.4 kb deletion within the TCF4 gene, removing exons 4-9. Parental array-CGH analysis was also performed, indicating paternal mosaicism for the same deletion. The mosaicism was confirmed by Quantitative Real-Time PCR. The current report describes a new TCF4 deletion associated with a PTHS phenotype. Moreover, it is the first case to our knowledge, where such a deletion is shown to be inherited from a clinically unaffected mosaic parent. Our results highlight the importance of parental testing in this setting for more accurate and focused prenatal diagnosis. The level and tissue-specificity of mosaicism in the father would be an interesting direction for further studies.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23528641     DOI: 10.1016/j.ejmg.2013.03.005

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  10 in total

Review 1.  Pitt-Hopkins Syndrome: A Review of Current Literature, Clinical Approach, and 23-Patient Case Series.

Authors:  Kimberly Goodspeed; Cassandra Newsom; Mary Ann Morris; Craig Powell; Patricia Evans; Sailaja Golla
Journal:  J Child Neurol       Date:  2018-01-10       Impact factor: 1.987

Review 2.  Evaluation of Nav1.8 as a therapeutic target for Pitt Hopkins Syndrome.

Authors:  Keri Martinowich; Debamitra Das; Srinidhi Rao Sripathy; Yishan Mai; Rakaia F Kenney; Brady J Maher
Journal:  Mol Psychiatry       Date:  2022-10-12       Impact factor: 13.437

3.  Disease-causing variants in TCF4 are a frequent cause of intellectual disability: lessons from large-scale sequencing approaches in diagnosis.

Authors:  Laura Mary; Amélie Piton; Elise Schaefer; Francesca Mattioli; Elsa Nourisson; Claire Feger; Claire Redin; Magali Barth; Salima El Chehadeh; Estelle Colin; Christine Coubes; Laurence Faivre; Elisabeth Flori; David Geneviève; Yline Capri; Laurence Perrin; Jennifer Fabre-Teste; Dana Timbolschi; Alain Verloes; Robert Olaso; Anne Boland; Jean-François Deleuze; Jean-Louis Mandel; Bénédicte Gerard; Irina Giurgea
Journal:  Eur J Hum Genet       Date:  2018-04-26       Impact factor: 4.246

4.  Fragile X syndrome screening in Chinese children with unknown intellectual developmental disorder.

Authors:  Xiaoli Chen; Jingmin Wang; Hua Xie; Wenjuan Zhou; Ye Wu; Jun Wang; Jian Qin; Jin Guo; Qiang Gu; Xiaozhen Zhang; Taoyun Ji; Yu Zhang; Zhiming Xiong; Liwen Wang; Xiru Wu; Gary J Latham; Yuwu Jiang
Journal:  BMC Pediatr       Date:  2015-07-15       Impact factor: 2.125

5.  Cryptic FMR1 mosaic deletion in a phenotypically normal mother of a boy with fragile X syndrome: case report.

Authors:  Shiyu Luo; Wen Huang; Qiuping Xia; Yan Xia; Qian Du; Lingqian Wu; Ranhui Duan
Journal:  BMC Med Genet       Date:  2014-11-25       Impact factor: 2.103

Review 6.  Copy number variation analysis in the context of electronic medical records and large-scale genomics consortium efforts.

Authors:  John J Connolly; Joseph T Glessner; Berta Almoguera; David R Crosslin; Gail P Jarvik; Patrick M Sleiman; Hakon Hakonarson
Journal:  Front Genet       Date:  2014-03-18       Impact factor: 4.599

7.  Complex translocation disrupting TCF4 and altering TCF4 isoform expression segregates as mild autosomal dominant intellectual disability.

Authors:  Valerie Maduro; Barbara N Pusey; Praveen F Cherukuri; Paul Atkins; Christèle du Souich; Rosemarie Rupps; Marjolaine Limbos; David R Adams; Samarth S Bhatt; Patrice Eydoux; Amanda E Links; Anna Lehman; May C Malicdan; Christopher E Mason; Marie Morimoto; James C Mullikin; Andrew Sear; Clara Van Karnebeek; Pawel Stankiewicz; William A Gahl; Camilo Toro; Cornelius F Boerkoel
Journal:  Orphanet J Rare Dis       Date:  2016-05-14       Impact factor: 4.123

8.  A case of Pitt-Hopkins syndrome presented with Angelman-like syndromic phenotypes.

Authors:  Syuan-Yu Hong; I-Ching Chou; Wei-De Lin; Fuu-Jen Tsai
Journal:  Biomedicine (Taipei)       Date:  2016-11-19

Review 9.  Molecular and Cellular Function of Transcription Factor 4 in Pitt-Hopkins Syndrome.

Authors:  Huei-Ying Chen; Joseph F Bohlen; Brady J Maher
Journal:  Dev Neurosci       Date:  2021-06-16       Impact factor: 3.421

10.  Two unrelated individuals carrying rare mosaic deletions in TCF4 gene.

Authors:  Ludmila Kousoulidou; Angelos Alexandrou; Ioannis Papaevripidou; Paola Evangelidou; George Tanteles; Violetta C Anastasiadou; Carolina Sismani
Journal:  Am J Med Genet A       Date:  2018-11-18       Impact factor: 2.802

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.